Poly Medicure Ltd.

•
₹ 1,719.4-2.84%

2026-08-21

polymedicure.comBSE: 531768NSE: POLYMED
Market Cap₹ 17,904 Cr.
Current Price₹ 1,719
High / Low₹ 2,145 / 1,182
Stock P/E0.0
Book Value₹ 309
Price to Book3.96
Dividend Yield0.20 %
ROCE14.9 %
ROE11.6 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2023 • Medical Devices: 100.0%

PROS

  • Company has delivered good profit growth of 21.0% CAGR over last 5 years
  • Company is almost debt free
  • Company has delivered good sales growth of 17.3% CAGR over last 5 years
  • Company comfortably covers its interest (29.9x coverage)
  • Stock looks reasonably valued - P/E of 35.9 is below its historical median
  • Working capital cycle has improved - days down from 346 to 266

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • A large part of profit comes from other income (27.9% of PBT)
  • Promoter holding has decreased over last 2 years: -3.6pp
  • Total debt has risen sharply - up 46.3% year on year
  • Though reporting repeated profits, the company pays out little dividend (10.6%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcareMedical Equipment/Supplies/Accessories
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.LENSKART654.40173.67113820.200.002284.303634.3527141.801332.6912.5521.70
2.POLYMED1766.4056.8217904.490.2085.27-8.39525.3830.3014.0524.11
3.MOLBIO1032.4071.4211897.380.00————19.79—
4.LAXMIDENTL199.3535.511096.850.0010.3223.8374.7016.1324.9620.26
5.3BBLACKBIO1138.5017.60977.140.448.98-28.9933.4950.5926.0325.45
6.GKB61.909.6231.200.001.85387.9933.042.268.827.97
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
306
220
Operating Profit
—
OPM %
—
Other Income
13
Interest
2
Depreciation
15
81
Tax %
25.15%
Net Profit
61
6
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
320
237
Operating Profit
—
OPM %
—
Other Income
13
Interest
2
Depreciation
15
78
Tax %
24.06%
Net Profit
59
6
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
321
236
Operating Profit
—
OPM %
—
Other Income
17
Interest
3
Depreciation
16
82
Tax %
25.13%
Net Profit
61
6
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
361
264
Operating Profit
—
OPM %
—
Other Income
16
Interest
3
Depreciation
16
94
Tax %
24.94%
Net Profit
71
7
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
367
266
Operating Profit
—
OPM %
—
Other Income
17
Interest
3
Depreciation
19
96
Tax %
24.74%
Net Profit
72
8
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
402
290
Operating Profit
—
OPM %
—
Other Income
27
Interest
3
Depreciation
20
117
Tax %
25.41%
Net Profit
87
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
411
295
Operating Profit
—
OPM %
—
Other Income
22
Interest
3
Depreciation
21
113
Tax %
24.91%
Net Profit
85
8
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
421
305
Operating Profit
—
OPM %
—
Other Income
24
Interest
2
Depreciation
21
116
Tax %
25.61%
Net Profit
87
8
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
384
282
Operating Profit
—
OPM %
—
Other Income
41
Interest
3
Depreciation
23
117
Tax %
24.89%
Net Profit
88
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
417
305
Operating Profit
—
OPM %
—
Other Income
34
Interest
3
Depreciation
24
118
Tax %
24.54%
Net Profit
89
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
419
307
Operating Profit
—
OPM %
—
Other Income
30
Interest
4
Depreciation
25
106
Tax %
26.06%
Net Profit
78
8
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
443
322
Operating Profit
—
OPM %
—
Other Income
15
Interest
4
Depreciation
26
107
Tax %
24.51%
Net Profit
81
8
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
431
341
Operating Profit
—
OPM %
—
Other Income
29
Interest
4
Depreciation
26
119
Tax %
25.72%
Net Profit
88
1
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
439
345
Operating Profit
108
OPM %
24
Other Income
14
Interest
8
Depreciation
23
76
Tax %
26
Net Profit
56
EPS
6
Dividend Payout %
39
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2018
508
387
Operating Profit
136
OPM %
27
Other Income
14
Interest
11
Depreciation
28
96
Tax %
27
Net Profit
70
EPS
8
Dividend Payout %
25
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2019
587
453
Operating Profit
150
OPM %
26
Other Income
16
Interest
13
Depreciation
36
100
Tax %
34
Net Profit
66
EPS
8
Dividend Payout %
27
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2020
646
484
Operating Profit
181
OPM %
28
Other Income
19
Interest
20
Depreciation
39
122
Tax %
24
Net Profit
92
EPS
10
Dividend Payout %
19
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Mar 2021
747
537
Operating Profit
230
OPM %
31
Other Income
19
Interest
10
Depreciation
46
173
Tax %
25
Net Profit
130
EPS
15
Dividend Payout %
19
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Mar 2022
879
665
Operating Profit
253
OPM %
29
Other Income
39
Interest
5
Depreciation
53
195
Tax %
25
Net Profit
146
EPS
15
Dividend Payout %
16
Minority Interest
0
Share of Associates
0
Adjusted EPS
15
Minority Interest
0
Share of Associates
0
Adjusted EPS
15
Mar 2023
1,068
802
Operating Profit
303
OPM %
28
Other Income
36
Interest
10
Depreciation
56
237
Tax %
24
Net Profit
179
EPS
19
Dividend Payout %
16
Minority Interest
0
Share of Associates
0
Adjusted EPS
19
Minority Interest
0
Share of Associates
0
Adjusted EPS
19
Mar 2024
1,307
956
Operating Profit
409
OPM %
31
Other Income
58
Interest
13
Depreciation
62
335
Tax %
25
Net Profit
252
EPS
26
Dividend Payout %
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Mar 2025
1,602
1,154
Operating Profit
538
OPM %
34
Other Income
90
Interest
14
Depreciation
81
443
Tax %
25
Net Profit
331
EPS
33
Dividend Payout %
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
Mar 2026
1,662
1,219
Operating Profit
568
OPM %
34
Other Income
125
Interest
16
Depreciation
98
448
Tax %
25
Net Profit
336
EPS
33
Dividend Payout %
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
TTM
1,710
1,275
Operating Profit
—
OPM %
—
Other Income
107
Interest
15
Depreciation
101
449
Tax %
25
Net Profit
336
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
15%
5 Years:
17%
3 Years:
16%

COMPOUNDED PROFIT GROWTH

10 Years:
22%
5 Years:
21%
3 Years:
23%

STOCK PRICE CAGR

10 Years:
24%
5 Years:
14%
3 Years:
6%
1 Year:
-12%

RETURN ON EQUITY

10 Years:
18%
5 Years:
15%
3 Years:
15%
Last Year:
12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2017

Mar 24

1:1

Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 06, 2017, inter alia, to consider the following: 1. To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on December 31, 2016. 2. To consider declaration of 2nd interim dividend, to the Equity Shareholders of the Company for the current financial year 2016-17. 3. To consider the issue of Bonus Shares, subject to approval of shareholdeis to be obtained in this behalf.

Mar 2017
Equity Capital
44
225
49
Trade Payables
41
90
Total Liabilities
449
200
Capital Work in Progress
12
6
58
0
Cash & Bank
22
151
Total Assets
449
Total Debt
97
Net Working Capital
92
Contingent Liabilities
39
Book Value per Share
30.48
Face Value
5.00
Total Debt
97
Net Working Capital
92
Contingent Liabilities
39
Book Value per Share
30.48
Face Value
5.00
Mar 2018
Equity Capital
44
290
48
Trade Payables
43
129
Total Liabilities
555
256
Capital Work in Progress
10
18
69
0
Cash & Bank
20
182
Total Assets
555
Total Debt
127
Net Working Capital
134
Contingent Liabilities
48
Book Value per Share
37.87
Face Value
5.00
Total Debt
127
Net Working Capital
134
Contingent Liabilities
48
Book Value per Share
37.87
Face Value
5.00
Mar 2019
Equity Capital
44
335
59
Trade Payables
50
172
Total Liabilities
661
269
Capital Work in Progress
9
42
74
0
Cash & Bank
53
213
Total Assets
661
Total Debt
150
Net Working Capital
146
Contingent Liabilities
43
Book Value per Share
43.01
Face Value
5.00
Total Debt
150
Net Working Capital
146
Contingent Liabilities
43
Book Value per Share
43.01
Face Value
5.00
Mar 2020
Equity Capital
44
385
79
Trade Payables
60
203
Total Liabilities
772
324
Capital Work in Progress
17
58
101
0
Cash & Bank
22
250
Total Assets
772
Total Debt
190
Net Working Capital
117
Contingent Liabilities
58
Book Value per Share
48.63
Face Value
5.00
Total Debt
190
Net Working Capital
117
Contingent Liabilities
58
Book Value per Share
48.63
Face Value
5.00
Mar 2021
Equity Capital
48
905
63
Trade Payables
56
159
Total Liabilities
1,231
385
Capital Work in Progress
15
385
109
0
Cash & Bank
27
310
Total Assets
1,231
Total Debt
123
Net Working Capital
522
Contingent Liabilities
64
Book Value per Share
99.42
Face Value
5.00
Total Debt
123
Net Working Capital
522
Contingent Liabilities
64
Book Value per Share
99.42
Face Value
5.00
Mar 2022
Equity Capital
48
1,027
79
Trade Payables
78
102
Total Liabilities
1,334
447
Capital Work in Progress
37
384
150
0
Cash & Bank
8
307
Total Assets
1,334
Total Debt
109
Net Working Capital
538
Contingent Liabilities
69
Book Value per Share
112.14
Face Value
5.00
Total Debt
109
Net Working Capital
538
Contingent Liabilities
69
Book Value per Share
112.14
Face Value
5.00
Mar 2023
Equity Capital
48
1,184
123
Trade Payables
78
163
Total Liabilities
1,596
597
Capital Work in Progress
73
181
183
0
Cash & Bank
171
391
Total Assets
1,596
Total Debt
135
Net Working Capital
486
Contingent Liabilities
69
Book Value per Share
128.39
Face Value
5.00
Total Debt
135
Net Working Capital
486
Contingent Liabilities
69
Book Value per Share
128.39
Face Value
5.00
Mar 2024
Equity Capital
48
1,407
145
Trade Payables
89
205
Total Liabilities
1,894
831
Capital Work in Progress
67
221
193
259
Cash & Bank
137
187
Total Assets
1,894
Total Debt
160
Net Working Capital
464
Contingent Liabilities
113
Book Value per Share
151.59
Face Value
5.00
Total Debt
160
Net Working Capital
464
Contingent Liabilities
113
Book Value per Share
151.59
Face Value
5.00
Mar 2025
Equity Capital
51
2,691
167
Trade Payables
77
242
Total Liabilities
3,228
1,047
Capital Work in Progress
89
1,126
250
340
Cash & Bank
143
232
Total Assets
3,228
Total Debt
170
Net Working Capital
1,524
Contingent Liabilities
77
Book Value per Share
270.61
Face Value
5.00
Total Debt
170
Net Working Capital
1,524
Contingent Liabilities
77
Book Value per Share
270.61
Face Value
5.00
Mar 2026
Equity Capital
51
2,995
243
Trade Payables
85
268
Total Liabilities
3,641
1,217
Capital Work in Progress
90
1,243
281
442
Cash & Bank
43
324
Total Assets
3,641
Total Debt
248
Net Working Capital
1,220
Contingent Liabilities
56
Book Value per Share
300.44
Face Value
5.00
Total Debt
248
Net Working Capital
1,220
Contingent Liabilities
56
Book Value per Share
300.44
Face Value
5.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
55
Cash from Investing
-54
Cash from Financing
-1
0
Free Cash Flow
1
OCF / Net Profit
0.98
Cumulative 5-Year FCF
0
OCF / Net Profit
0.98
Cumulative 5-Year FCF
0
Mar 2018
75
Cash from Investing
-87
Cash from Financing
14
3
Free Cash Flow
-6
OCF / Net Profit
1.08
Cumulative 5-Year FCF
0
OCF / Net Profit
1.08
Cumulative 5-Year FCF
0
Mar 2019
113
Cash from Investing
-104
Cash from Financing
-10
-1
Free Cash Flow
70
OCF / Net Profit
1.71
Cumulative 5-Year FCF
0
OCF / Net Profit
1.71
Cumulative 5-Year FCF
0
Mar 2020
127
Cash from Investing
-106
Cash from Financing
-22
-1
Free Cash Flow
30
OCF / Net Profit
1.37
Cumulative 5-Year FCF
0
OCF / Net Profit
1.37
Cumulative 5-Year FCF
0
Mar 2021
116
Cash from Investing
-434
Cash from Financing
319
1
Free Cash Flow
13
OCF / Net Profit
0.90
Cumulative 5-Year FCF
108
OCF / Net Profit
0.90
Cumulative 5-Year FCF
108
Mar 2022
126
Cash from Investing
-89
Cash from Financing
-40
-2
Free Cash Flow
-5
OCF / Net Profit
0.86
Cumulative 5-Year FCF
102
OCF / Net Profit
0.86
Cumulative 5-Year FCF
102
Mar 2023
197
Cash from Investing
-189
Cash from Financing
-8
-0
Free Cash Flow
-37
OCF / Net Profit
1.10
Cumulative 5-Year FCF
71
OCF / Net Profit
1.10
Cumulative 5-Year FCF
71
Mar 2024
256
Cash from Investing
-237
Cash from Financing
-17
2
Free Cash Flow
-30
OCF / Net Profit
1.02
Cumulative 5-Year FCF
-29
OCF / Net Profit
1.02
Cumulative 5-Year FCF
-29
Mar 2025
230
Cash from Investing
-1,184
Cash from Financing
953
-2
Free Cash Flow
-75
OCF / Net Profit
0.69
Cumulative 5-Year FCF
-134
OCF / Net Profit
0.69
Cumulative 5-Year FCF
-134
Mar 2026
245
Cash from Investing
-268
Cash from Financing
28
5
Free Cash Flow
-15
OCF / Net Profit
0.73
Cumulative 5-Year FCF
-162
OCF / Net Profit
0.73
Cumulative 5-Year FCF
-162

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
EPS (₹)
6.37
Book Value (₹)
30.48
Dividend per Share (₹)
2.50
Cash EPS (₹)
8.97
Operating Margin %
24.11%
Net Margin %
12.59%
ROE %
22.81%
ROCE %
25.30%
13.62%
Debtor Days
72
Inventory Days
40
Payable Days
117
-5
Debt to Equity (x)
0.36x
Interest Coverage (x)
10.06x
1.85x
Revenue Growth %
11.41%
Operating Profit Growth %
13.51%
Net Profit Growth %
18.80%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
7.96
Book Value (₹)
37.87
Dividend per Share (₹)
2.00
Cash EPS (₹)
11.18
Operating Margin %
26.66%
Net Margin %
13.77%
ROE %
23.28%
ROCE %
25.96%
13.99%
Debtor Days
74
Inventory Days
45
Payable Days
127
-7
Debt to Equity (x)
0.38x
Interest Coverage (x)
9.67x
2.15x
Revenue Growth %
15.69%
Operating Profit Growth %
26.23%
Net Profit Growth %
24.91%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
7.51
Book Value (₹)
43.01
Dividend per Share (₹)
2.00
Cash EPS (₹)
11.63
Operating Margin %
25.43%
Net Margin %
11.23%
ROE %
18.58%
ROCE %
22.92%
10.91%
Debtor Days
73
Inventory Days
44
Payable Days
112
6
Debt to Equity (x)
0.40x
Interest Coverage (x)
8.63x
1.90x
Revenue Growth %
15.39%
Operating Profit Growth %
10.42%
Net Profit Growth %
-5.58%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
10.47
Book Value (₹)
48.63
Dividend per Share (₹)
2.00
Cash EPS (₹)
14.92
Operating Margin %
27.85%
Net Margin %
14.23%
ROE %
22.85%
ROCE %
24.64%
12.90%
Debtor Days
69
Inventory Days
49
Payable Days
131
-13
Debt to Equity (x)
0.44x
Interest Coverage (x)
7.16x
1.56x
Revenue Growth %
10.14%
Operating Profit Growth %
20.52%
Net Profit Growth %
39.37%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
13.51
Book Value (₹)
99.42
Dividend per Share (₹)
2.50
Cash EPS (₹)
18.34
Operating Margin %
30.57%
Net Margin %
17.24%
ROE %
18.74%
ROCE %
21.62%
12.93%
Debtor Days
65
Inventory Days
51
Payable Days
108
9
Debt to Equity (x)
0.13x
Interest Coverage (x)
18.43x
3.67x
Revenue Growth %
15.66%
Operating Profit Growth %
27.00%
Net Profit Growth %
40.19%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
15.23
Book Value (₹)
112.14
Dividend per Share (₹)
2.50
Cash EPS (₹)
20.70
Operating Margin %
28.59%
Net Margin %
16.52%
ROE %
14.40%
ROCE %
17.68%
11.39%
Debtor Days
70
Inventory Days
54
Payable Days
94
30
Debt to Equity (x)
0.10x
Interest Coverage (x)
37.30x
3.65x
Revenue Growth %
17.66%
Operating Profit Growth %
10.00%
Net Profit Growth %
12.74%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
18.66
Book Value (₹)
128.39
Dividend per Share (₹)
3.00
Cash EPS (₹)
24.46
Operating Margin %
28.22%
Net Margin %
16.69%
ROE %
15.52%
ROCE %
19.34%
12.22%
Debtor Days
70
Inventory Days
57
Payable Days
95
32
Debt to Equity (x)
0.11x
Interest Coverage (x)
24.23x
2.49x
Revenue Growth %
21.46%
Operating Profit Growth %
19.81%
Net Profit Growth %
22.62%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
26.23
Book Value (₹)
151.59
Dividend per Share (₹)
3.00
Cash EPS (₹)
32.64
Operating Margin %
26.75%
Net Margin %
19.18%
ROE %
18.74%
ROCE %
23.28%
14.43%
Debtor Days
67
Inventory Days
52
Payable Days
84
35
Debt to Equity (x)
0.11x
Interest Coverage (x)
27.06x
2.16x
Revenue Growth %
22.40%
Operating Profit Growth %
35.24%
Net Profit Growth %
40.59%
40.55%
P/E (x)
60.57x
P/B (x)
10.48x
Dividend Yield %
0.19%
37.31x
Mar 2025
EPS (₹)
32.70
Book Value (₹)
270.61
Dividend per Share (₹)
3.50
Cash EPS (₹)
40.73
Operating Margin %
27.84%
Net Margin %
20.59%
ROE %
15.79%
ROCE %
20.14%
12.94%
Debtor Days
68
Inventory Days
50
Payable Days
71
47
Debt to Equity (x)
0.06x
Interest Coverage (x)
33.80x
4.55x
Revenue Growth %
22.53%
Operating Profit Growth %
31.39%
Net Profit Growth %
31.63%
24.67%
P/E (x)
68.57x
P/B (x)
8.29x
Dividend Yield %
0.16%
42.29x
Mar 2026
EPS (₹)
33.15
Book Value (₹)
300.44
Dividend per Share (₹)
3.50
Cash EPS (₹)
42.81
Operating Margin %
26.47%
Net Margin %
20.07%
ROE %
11.61%
ROCE %
14.91%
9.78%
Debtor Days
85
Inventory Days
58
Payable Days
70
74
Debt to Equity (x)
0.08x
Interest Coverage (x)
29.86x
3.39x
Revenue Growth %
3.79%
Operating Profit Growth %
5.64%
Net Profit Growth %
1.40%
1.37%
P/E (x)
35.92x
P/B (x)
3.96x
Dividend Yield %
0.29%
21.61x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
66.03
9.91
9.34
Government
0.00
14.72
Sep 2024
62.56
11.86
12.33
Government
0.00
13.24
Dec 2024
62.44
12.31
11.66
Government
0.00
13.57
Mar 2025
62.44
11.44
11.96
Government
0.00
14.15
Jun 2025
62.44
11.41
11.72
Government
0.00
14.44
Sep 2025
62.42
9.77
13.53
Government
0.00
14.27
Dec 2025
62.42
9.40
13.84
Government
0.00
14.34
Mar 2026
62.42
5.92
15.60
Government
0.00
16.08
Jun 2026
62.42
5.56
16.08
Government
0.00
15.94

Documents

Announcements

  • General Updates

    2026-08-20 - Investor Call Scheedule to be held on 20th August, 2026 is Cancelled

  • General Updates

    2026-08-17 - Poly Medicure Limited has informed the Exchange about the schedule of Investors/Analysts Call/Meet

Annual Reports

Credit Ratings

  • Credit Rating- Revision

    2026-06-26 - Poly Medicure Limited has informed the Exchange about Credit Rating- Outlook Revision and Rating Re-affirmed

Concalls